EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction

Ana M Briones iD, Raquel Hernanz, Ana B García-Redondo, Cristina Rodríguez, Luis M Blanco-Colio, Almudena Val-Blasco, María J Alonso iD, Mercedes Salaices

Basic & Clinical Pharmacology & Toxicology · 2025-05 · 136 (5)

DOI: 10.1111/bcpt.70026 ↗

At a glance

Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2025-03-31. Written by Ana M Briones and 7 co-authors. Institution: Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. Major MEDLINE topics: Inflammation, Endothelium, Vascular, Inflammation Mediators, Cardiovascular Diseases. Cited 25 times so far (Crossref); 99 references. The full text is freely available in PubMed Central. Funded by: Agencia Estatal de Investigación, Comunidad de Madrid, Fundación Española de Arteriosclerosis.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti‐inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro‐resolving mediators (SPMs) that act on cognate G protein–coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega‐3 and omega‐6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.

Subjects

MeSH terms (MEDLINE)

InflammationEndothelium, VascularInflammation MediatorsCardiovascular DiseasesHumansAnimalsReceptors, G-Protein-CoupledOxidative StressNitric OxideAnti-Inflammatory AgentsCytokines

Author keywords

cardiovascular diseasesendothelial dysfunctionhypertensioninflammationspecialized proresolvin mediators

Substances

Inflammation MediatorsReceptors, G-Protein-CoupledNitric OxideAnti-Inflammatory AgentsCytokines

Authors and institutions

  • Department of Pharmacology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain.
  • CIBER Cardiovascular (CIBERCV), Madrid, Spain.
  • Department of Basic Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain.
  • Department of Physiology, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.

ORCID profiles: Ana M Briones, María J Alonso

Funding

  • Agencia Estatal de Investigación
  • Comunidad de Madrid
  • Fundación Española de Arteriosclerosis
  • Instituto de Salud Carlos III
  • European Union
  • European Commission

Cite

APA

Briones, A. M., Hernanz, R., García-Redondo, A. B., Rodríguez, C., Blanco-Colio, L. M., Val-Blasco, A., Alonso, M. J., & Salaices, M. (2025). Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. Basic & Clinical Pharmacology & Toxicology, 136(5). https://doi.org/10.1111/bcpt.70026

Vancouver

Briones AM, Hernanz R, García-Redondo AB, Rodríguez C, Blanco-Colio LM, Val-Blasco A, et al. Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction. Basic & Clinical Pharmacology & Toxicology. 2025;136(5). doi:10.1111/bcpt.70026

BibTeX
@article{Briones2025,
  author = {Briones, Ana M and Hernanz, Raquel and García-Redondo, Ana B and Rodríguez, Cristina and Blanco-Colio, Luis M and Val-Blasco, Almudena and Alonso, María J and Salaices, Mercedes},
  title = {Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {136},
  number = {5},
  doi = {10.1111/bcpt.70026}
}
Start for free →